Federal Register of Legislation - Australian Government

Primary content

This instrument determines certain bodies to be overseas regulators for the purposes of section 41BIB of the Therapeutic Goods Act 1989.
Administered by: Health
Registered 16 Apr 2019
Start Date 10 Apr 2019
Table of contents.

Commonwealth Coat of Arms of Australia

 

Therapeutic Goods (Overseas Regulators) Determination 2018

made under subsection 41BIB(2) of the

Therapeutic Goods Act 1989

Compilation No. 1

Compilation date:                          10 April 2019

Includes amendments up to:         Therapeutic Goods Amendment (Overseas Regulators) Determination 2019

 

 

 


About this compilation

This compilation

This is a compilation of the Therapeutic Goods (Overseas Regulators) Determination 2018 that shows the text of the law as amended and in force on 10 April 2019 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.

Self‑repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

  

  

  


Contents

1  Name........................................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Definitions................................................................................................................................ 1

5  Overseas regulators.................................................................................................................. 2

Endnotes                                                                                                                        3

Endnote 1—About the endnotes                                                                              3

Endnote 2—Abbreviation key                                                                                 4

Endnote 3—Legislation history                                                                              5

Endnote 4—Amendment history                                                                             6

 


1  Name

                   This instrument is the Therapeutic Goods (Overseas Regulators) Determination 2018.

3  Authority

                   This instrument is made under subsection 41BIB(2) of the Therapeutic Goods Act 1989.

4  Definitions

Note:       A number of expressions used in this instrument are defined in the Act, including the following:

(a)      overseas regulator; and

(b)     medical device.

In this instrument:

Act means Therapeutic Goods Act 1989.

active implantable medical device has the same meaning as in the Regulations.

IAF accredited conformity assessment body means a body that is accredited to undertake certification for compliance with ISO 13485 by an accreditation body member that is a signatory to the Multilateral Recognition Arrangement of the International Accreditation Forum, Inc., otherwise known as the IAF MLA.

in vitro diagnostic medical device has the same meaning as in the Regulations.

ISO 13485 means International Standard ISO 13485:2016 Medical devices¾Quality management systems¾Requirements for regulatory purposes, issued by the International Organization for Standardization in March 2016, as in force or existing immediately before the commencement of this instrument.

Note:       ISO 13485 is published at: https://www.iso.org.

notified body means a body that has been designated by a member state of the European Union, and notified to the European Commission, to assess the conformity of medical devices, including in vitro diagnostic medical devices and active implantable medical devices.


 

recognised auditing organisation means an organisation authorised to perform audits under the Medical Device Single Audit Program by the Regulatory Authority Council, in relation to that program, comprising the Australian Therapeutic Goods Administration, the United States Food and Drug Administration, the Brazilian Agência Nacional de Vigilância Sanitária, Health Canada, and Japan’s Ministry of Health, Labour and Welfare and the Japanese Pharmaceuticals and Medical Devices Agency.

Regulations means the Therapeutic Goods (Medical Devices) Regulations 2002.

Overseas regulators

Each of the following is determined to be an overseas regulator for the purposes of subsection 41BIB(1) of the Act:

                    (aa)  an IAF accredited conformity assessment body;

                     (a)  a notified body;

                     (b)  a recognised auditing organisation;

                     (c)  Health Canada;

                     (d)  Japan’s Ministry of Health, Labour and Welfare;

                     (e)  the Japanese Pharmaceuticals and Medical Devices Agency;

                      (f)  the United States Food and Drug Administration.

 


Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.

If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history.

Endnote 2—Abbreviation key

 

ad = added or inserted

o = order(s)

am = amended

Ord = Ordinance

amdt = amendment

orig = original

c = clause(s)

par = paragraph(s)/subparagraph(s)

C[x] = Compilation No. x

    /sub‑subparagraph(s)

Ch = Chapter(s)

pres = present

def = definition(s)

prev = previous

Dict = Dictionary

(prev…) = previously

disallowed = disallowed by Parliament

Pt = Part(s)

Div = Division(s)

r = regulation(s)/rule(s)

ed = editorial change

reloc = relocated

exp = expires/expired or ceases/ceased to have

renum = renumbered

    effect

rep = repealed

F = Federal Register of Legislation

rs = repealed and substituted

gaz = gazette

s = section(s)/subsection(s)

LA = Legislation Act 2003

Sch = Schedule(s)

LIA = Legislative Instruments Act 2003

Sdiv = Subdivision(s)

(md) = misdescribed amendment can be given

SLI = Select Legislative Instrument

    effect

SR = Statutory Rules

(md not incorp) = misdescribed amendment

Sub‑Ch = Sub‑Chapter(s)

    cannot be given effect

SubPt = Subpart(s)

mod = modified/modification

underlining = whole or part not

No. = Number(s)

    commenced or to be commenced

 

Endnote 3—Legislation history

 

Name

Registration

Commencement

Application, saving and transitional provisions

Therapeutic Goods (Overseas Regulators) Determination 2018

11 Sep 2018 (F2018N00145)

12 Sep 2018

Therapeutic Goods Amendment (Overseas Regulators) Determination 2019

9 Apr 2019 (F2019N00039)

10 Apr 2019

 


 

Endnote 4—Amendment history

 

Provision affected

How affected

s 2........................................

rep LA s 48D

s 3........................................

am F2019N00039

s 4........................................

am F2019N00039

s 5........................................

am F2019N00039